| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
This prospectus supplement and the related prospectus relate to the offer and resale by the selling stockholder identified in this prospectus supplement of up to 1,182,070 shares of our common stock, par value $1.00 per share (our "common stock"). We issued the shares of common stock covered by this prospectus supplement to the selling stockholder as consideration for our recent acquisition of certain properties (the "Transaction"). This prospectus supplement amends and restates the prospectus supplement, dated July 29, 2025, to register additional shares of our common stock that may be offered and resold by the selling stockholder.
We will not receive any of the proceeds from any sale of the shares by the selling stockholder. The selling stockholder from time to time may offer and sell shares of our common stock held by it directly or through agents or broker-dealers on terms to be determined at the time of sale, as described in more detail in this prospectus supplement.
Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "WELL." On October 27, 2025, the last reported sale price of our common stock on the NYSE was $182.61 per share.
Posted In: WELL
